Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 11351 to 11375

BOLSTRAN omalizumab (rch) 150mg powder for injection vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

14 July 2021

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
DBL STERILE CARDIOPLEGIA CONCENTRATE injection ampoule Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
HOSPIRA GLYCERYL TRINITRATE CONCENTRATE INJECTION glyceryl trinitrate 50mg/10mL injection ampoule Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
HOSPIRA HYOSCINE HYDROBROMIDE INJECTION hyoscine hydrobromide (as trihydrate) 400 microgram/1mL injection ampoule Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
PANTO HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTO pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTO pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTO pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTO pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
Pfizer (Australia) ONDANSETRON INJECTION ondansetron 4mg/2mL (as hydrochloride dihydrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
Pfizer (Australia) ONDANSETRON INJECTION ondansetron 8mg/4mL (as hydrochloride dihydrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
Ultra Zinc + Cancelled under Section 30(1)(c) of the Act

12 July 2021

Cancellation by sponsor

Requested by Herbs of Gold Pty Ltd
HYDRA-ION REHYDR8 Apple Blackcurrant Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

9 July 2021

Cancellation by sponsor

Requested by Twisobell Health Pty Ltd
HYDRA-ION REHYDR8 Lemon Lime Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

9 July 2021

Cancellation by sponsor

Requested by Twisobell Health Pty Ltd
HYDRA-ION REHYDR8 Orange Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

9 July 2021

Cancellation by sponsor

Requested by Twisobell Health Pty Ltd
TRANEXAMIC ACID JN tranexamic acid 1000 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
TRANEXAMIC ACID JN tranexamic acid 500mg/5mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
TRANEXID tranexamic acid 1000 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
TRANEXID tranexamic acid 500mg/5mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
VISUDYNE verteporfin 15mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

8 July 2021

Cancellation by sponsor

Requested by Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Aesthetics Light Sunscreen SPF50+ Cancelled under Section 30(1)(c) of the Act

5 July 2021

Cancellation by sponsor

Requested by AESTHETICS SKINCARE PTY LTD
Aesthetics Tinted Sunscreen SPF50+ Cancelled under Section 30(1)(c) of the Act

5 July 2021

Cancellation by sponsor

Requested by AESTHETICS SKINCARE PTY LTD
All Sports Spray Cancelled under Section 30(1)(c) of the Act

5 July 2021

Cancellation by sponsor

Requested by RNW Nominees Pty Ltd The Trustee for R & N Family Trust
ATELVIA EC ONCE-A-WEEK risedronate sodium 35mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 July 2021

Cancellation by sponsor

Requested by Theramex Australia Pty Ltd
Bone Health - Calcium + Vitamin D Cancelled under Section 30(1)(c) of the Act

5 July 2021

Cancellation by sponsor

Requested by Bondi Vite Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

BOLSTRAN omalizumab (rch) 150mg powder for injection vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

DBL STERILE CARDIOPLEGIA CONCENTRATE injection ampoule Cancelled under Section 30(1)(c) of the Act

HOSPIRA GLYCERYL TRINITRATE CONCENTRATE INJECTION glyceryl trinitrate 50mg/10mL injection ampoule Cancelled under Section 30(1)(c) of the Act

HOSPIRA HYOSCINE HYDROBROMIDE INJECTION hyoscine hydrobromide (as trihydrate) 400 microgram/1mL injection ampoule Cancelled under Section 30(1)(c) of the Act

PANTO HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

PANTO pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

PANTO pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

PANTO pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

PANTO pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

Pfizer (Australia) ONDANSETRON INJECTION ondansetron 4mg/2mL (as hydrochloride dihydrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

Pfizer (Australia) ONDANSETRON INJECTION ondansetron 8mg/4mL (as hydrochloride dihydrate) injection ampoule Cancelled under Section 30(1)(c) of the Act

Ultra Zinc + Cancelled under Section 30(1)(c) of the Act

HYDRA-ION REHYDR8 Apple Blackcurrant Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

HYDRA-ION REHYDR8 Lemon Lime Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

HYDRA-ION REHYDR8 Orange Effervescent Electrolyte Tablets Cancelled under Section 30(1)(c) of the Act

TRANEXAMIC ACID JN tranexamic acid 1000 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

TRANEXAMIC ACID JN tranexamic acid 500mg/5mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

TRANEXID tranexamic acid 1000 mg/10 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

TRANEXID tranexamic acid 500mg/5mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

VISUDYNE verteporfin 15mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

Aesthetics Light Sunscreen SPF50+ Cancelled under Section 30(1)(c) of the Act

Aesthetics Tinted Sunscreen SPF50+ Cancelled under Section 30(1)(c) of the Act

All Sports Spray Cancelled under Section 30(1)(c) of the Act

ATELVIA EC ONCE-A-WEEK risedronate sodium 35mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

Bone Health - Calcium + Vitamin D Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?